CME Group Inc. (NASDAQ:CME) Shares Acquired by Keyes Stange & Wooten Wealth Management LLC

Keyes Stange & Wooten Wealth Management LLC boosted its position in CME Group Inc. (NASDAQ:CME) by 3.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,585 shares of the financial services provider’s stock after purchasing an additional 103 shares during the period. CME Group comprises 0.5% of Keyes Stange & Wooten Wealth Management LLC’s investment portfolio, making the stock its 27th biggest position. Keyes Stange & Wooten Wealth Management LLC’s holdings in CME Group were worth $791,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CME. Y.D. More Investments Ltd purchased a new stake in shares of CME Group in the second quarter valued at about $36,000. Thurston Springer Miller Herd & Titak Inc. grew its holdings in CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after buying an additional 74 shares during the last quarter. McClarren Financial Advisors Inc. grew its holdings in CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after buying an additional 78 shares during the last quarter. Asset Dedication LLC increased its position in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after buying an additional 170 shares in the last quarter. Finally, New Covenant Trust Company N.A. acquired a new position in shares of CME Group in the first quarter worth $82,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently commented on CME. Oppenheimer lifted their price objective on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research report on Thursday, October 24th. Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a report on Tuesday, October 8th. Citigroup upped their price objective on shares of CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research note on Thursday, October 24th. Piper Sandler raised their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Monday, October 28th. Finally, The Goldman Sachs Group boosted their price target on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a report on Thursday, October 3rd. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, CME Group has a consensus rating of “Hold” and an average target price of $224.47.

Insider Transactions at CME Group

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This trade represents a 5.38 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now directly owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This trade represents a 1.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,621 shares of company stock valued at $3,441,063. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of CME stock opened at $229.04 on Friday. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.74. The company has a market capitalization of $82.54 billion, a PE ratio of 24.08, a price-to-earnings-growth ratio of 5.23 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm has a fifty day simple moving average of $223.64 and a 200-day simple moving average of $211.07.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company’s revenue was up 18.4% on a year-over-year basis. During the same period last year, the firm earned $2.25 earnings per share. Equities research analysts anticipate that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.01%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio is currently 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.